Skip to main content
Clinical Trials/NCT02847273
NCT02847273
Completed
Not Applicable

Peripheral Four-wavelength Near-infrared Spectroscopy Measurement: a Comparison Between EQUANOX and O3 in Cardiac Surgery

Hospices Civils de Lyon1 site in 1 country20 target enrollmentSeptember 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Conventional Cardiac Surgery With Bypass
Sponsor
Hospices Civils de Lyon
Enrollment
20
Locations
1
Primary Endpoint
Peripheral absolute rSO2 values
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Near-infrared spectroscopy (NIRS) is a continuous and non-invasive technology that measures regional tissue oxygen saturation (rSO2). Whatever the anatomical site of measurement, a normal value of rSO2 would suggest a good adequacy between oxygen supply and consumption at the regional level. Beside the trend ability of previous 2 or 3-wavelength devices, a new 4-wavelength generation of NIRS monitors which could reliably assess real-time absolute values of rSO2 is now available. The investigators aimed to compare peripheral absolute rSO2 values given by the 4-wavelength EQUANOX device 7600 (Nonin Medical, Plymouth, Mn) and the new O3 device (Masimo, Irvine, CA) during conventional cardiac surgery.

Registry
clinicaltrials.gov
Start Date
September 2015
End Date
December 2015
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age \>18 years
  • Scheduled for conventional elective cardiac surgery with cardiopulmonary bypass
  • Hospitalized in the Teaching University Hospital Louis Pradel (Lyon, France)
  • Patient agreement

Exclusion Criteria

  • Age\<18 years
  • Black skin
  • Emergencies
  • Patient refusal

Outcomes

Primary Outcomes

Peripheral absolute rSO2 values

Time Frame: at conventional cardiac surgery (Day 1)

Peripheral absolute rSO2 values given by the 4-wavelength EQUANOX device 7600 (Nonin Medical, Plymouth, Mn) and the new O3 device (Masimo, Irvine, CA) during conventional cardiac surgery.

Secondary Outcomes

  • heart rate(at conventional cardiac surgery (Day 1))
  • Arterial pressure(at conventional cardiac surgery (Day 1))
  • pulse oxygen saturation(at conventional cardiac surgery (Day 1))
  • Inotrope drugs doses(at conventional cardiac surgery (Day 1))
  • bispectral index(at conventional cardiac surgery (Day 1))

Study Sites (1)

Loading locations...

Similar Trials